Patent Assignment
Reel/Frame 027683/0003
Security Agreement
Recorded: 2012-02-09
Pages: 10
Assignor
AERIS THERAPEUTICS, LLC
Executed: 2012-01-31
Assignee
ROSSE ENTERPRISES, LTD.
10 SPEEN STREET, 4TH FLOOR, FRAMINGHAM, MASSACHUSETTS, 01701
Covered Properties
(23)
Compositions and Methods for Reducing Lung Volume
PCT:
PCT/US2003/019339 ↗
Compositions and Methods for Reducing Lung Volume
PCT:
PCT/US2005/046016 ↗
Polymer Systems for Lung Volume Reduction Therapy
PCT:
PCT/US2007/079504 ↗
Lung Volume Reduction Therapy Using Crosslinked Biopolymers
PCT:
PCT/US2008/059263 ↗
Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers
PCT:
PCT/US2008/062993 ↗
Tissue Volume Reduction
Patent:
6,610,043 →
Application:
09/379,460 →
Tissue Volume Reduction
Tissue Volume Reduction
Patent:
7,654,998 →
Application:
10/069,307 →
Compositions and methods for reducing lung volume
Application:
10/464,115 →
Publication:
US 2004/0047855
Tissue Volume Reduction
Tissue Volume Reduction
Compositions and Methods for Reducing Lung Volume
Respiratory Assistance Apparatus and Method
Lung Volume Reduction Therapy Using Crosslinked Biopolymers
Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers
Polymer Systems for Lung Volume Reduction Therapy
Compositions and methods for reducing lung volume
Application:
60/389,731 →
Compositions and methods for reducing lung volume
Application:
60/530,832 →
Respiratory assistance apparatus and method
Application:
60/817,987 →
Respiratory assistance apparatus and method
Application:
60/818,361 →
Polymer systems for lung-volume reduction therapy
Application:
60/847,328 →
Lung Volume Reduction Therapy Using Crosslinked Mammalian Biopolymers
Application:
60/909,806 →
Lung Volume Reduction Therapy Using Crosslinked Aminated Polyvinyl Alcohol
Application:
60/917,419 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 22, 2011
From: AERIS THERAPEUTICS, INC.
To: AERIS THERAPEUTICS, LLC
Reel/Frame 026170/0254 →
Release of Security Interest
May 26, 2015
From: ROSSE ENTERPRISES, LTD.
To: AERIS THERAPEUTICS, LLC.
Reel/Frame 035714/0886 →
Assignment of Assignor's Interest
May 26, 2015
From: AERIS THERAPEUTICS, LLC.
To: PULMONX CORPORATION
Reel/Frame 035715/0265 →
Security Interest
May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
Security Interest
Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
Assignment of Assignor's Interest
Mar 25, 2019
From: AERIS THERAPEUTICS, LLC.
To: PULMONX
Reel/Frame 048682/0506 →
Merger
Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0822 →
Security Interest
Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
Release of Security Interest
Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
Release of Security Interest
Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
Security Interest
Nov 30, 2022
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 061929/0750 →
Security Interest
Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
Security Interest
Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
Release of Security Interest
Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
Release of Security Interest
Mar 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 073980/0673 →